510(k) K781235
K781235 is an FDA 510(k) premarket notification submitted by Clinical Assays, Inc. for the device "IV VITRO GAMMADAB T4 RIA KIT". The FDA issued a decision of Substantially Equivalent on August 14, 1978. The device falls under product code CDX (Radioimmunoassay, Total Thyroxine), a Class II device regulated under 21 CFR 862.1700. Clinical Assays, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 14, 1978
- Date Received
- July 19, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Total Thyroxine
- Device Class
- Class II
- Regulation Number
- 862.1700
- Review Panel
- CH
- Submission Type